Warren Foust - Mar 12, 2024 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
Chief Operating Officer
Signature
/s/ Nathaniel Sisitsky as attorney-in-fact for Warren Foust
Stock symbol
STAA
Transactions as of
Mar 12, 2024
Transactions value $
$0
Form type
4
Date filed
3/14/2024, 05:19 PM
Previous filing
May 9, 2023
Next filing
May 9, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Restricted Stock Units Award $0 +24.5K $0.00 24.5K Mar 12, 2024 Common Stock 24.5K $0.00 Direct F1, F2
transaction STAA Common Stock Options Award $0 +22K +73220% $0.00 22K Mar 12, 2024 Common Stock 22K $37.64 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting.
F2 RSUs granted to the Reporting Person on March 12, 2024. RSUs will vest as to 1/3 (8,175 shares) on March 12, 2025, 1/3 (8,175 shares) on March 12, 2026, and 1/3 (8,175 shares) on March 12, 2027.
F3 Stock options granted to the Reporting Person on March 12, 2024. Options will vest and become exercisable as to 1/3 (7,322 shares) on March 12, 2025, with the remaining 2/3 (14,644 shares) vesting and becoming exercisable monthly over the following 24 months in equal amounts on a monthly basis. In the event such amount does not evenly divide into 24 months, the remaining balance of options will vest and become exercisable on March 12, 2027.